A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis
Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate...
Saved in:
Published in | Virology journal Vol. 18; no. 1; p. 84 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
21.04.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus.
Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection.
Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues.
The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. |
---|---|
AbstractList | Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1[beta], IL-6, IL-18, and IFN-[gamma] in nasal mucosa, lungs and brain tissues. The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. BACKGROUNDCoxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. METHODSCoxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. RESULTSWeight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. CONCLUSIONSThe hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Methods Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Results Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1[beta], IL-6, IL-18, and IFN-[gamma] in nasal mucosa, lungs and brain tissues. Conclusions The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. Keywords: Coxsackievirus A16 (CA16), Hand, Foot and mouth disease (HFMD), Human scavenger receptor class B, member 2 (hSCARB2), Respiratory and neurological pathology Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD), but its pathogenesis is not yet clear. The limited host range of CA16 make the establishment of a suitable animal model that can recapitulate the neurological pathology observed in human HFMD more difficult. Because the human scavenger receptor class B, member 2 (hSCARB2) is a cellular receptor for CA16, we used transgenic mice bearing human SCARB2 and nasally infected them with CA16 to study the pathogenicity of the virus. Coxsackievirus A16 was administered by intranasal instillation to groups of hSCARB2 transgenic mice and clinical signs were observed. Sampled at different time-points to document and characterize the mode of viral dissemination, pathological change and immune response of CA16 infection. Weight loss and virus replication in lung and brain were observed in hSCARB2 mice infected with CA16, indicating that these animals could model the neural infection process. Viral antigens were observed in the alveolar epithelia and brainstem cells. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes into the alveolar interstitial in lung and diffuse punctate hemorrhages in the capillaries of the brainstem. In addition, we detected the expression levels of inflammatory cytokines and detected high levels of interleukin IL-1β, IL-6, IL-18, and IFN-γ in nasal mucosa, lungs and brain tissues. The hSCARB2-transgenic mice can be productively infected with CA16 via respiratory route and exhibited a clear tropism to lung and brain tissues, which can serve as a model to investigate the pathogenesis of CA16 associated respiratory and neurological disease. |
ArticleNumber | 84 |
Audience | Academic |
Author | Chen, Yanli Yang, Jinxi Song, Jie Liu, Longding Li, Heng Li, Weiyu Yang, Zening Guo, Lei Zheng, Huiwen |
Author_xml | – sequence: 1 givenname: Yanli surname: Chen fullname: Chen, Yanli organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 2 givenname: Heng surname: Li fullname: Li, Heng organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 3 givenname: Jinxi surname: Yang fullname: Yang, Jinxi organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 4 givenname: Huiwen surname: Zheng fullname: Zheng, Huiwen organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 5 givenname: Lei surname: Guo fullname: Guo, Lei organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 6 givenname: Weiyu surname: Li fullname: Li, Weiyu organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 7 givenname: Zening surname: Yang fullname: Yang, Zening organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China – sequence: 8 givenname: Jie surname: Song fullname: Song, Jie email: songjie@imbcams.com.cn, songjie@imbcams.com.cn organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China. songjie@imbcams.com.cn – sequence: 9 givenname: Longding orcidid: 0000-0001-8335-5613 surname: Liu fullname: Liu, Longding email: longdingl@gmail.com, longdingl@gmail.com organization: Key Laboratory of Systemic Innovative Research on Virus Vaccine, Chinese Academy of Medical Sciences, Kunming, 650118, China. longdingl@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33882964$$D View this record in MEDLINE/PubMed |
BookMark | eNptkltrFDEUxwep2It-AR9kwBd9mJqcXCZ5Edb1tlAQWgXfQiaX3ayzkzWZKfXbm-3W2hUJJOHkd_4n5_A_rY6GOLiqeo7ROcaCv8kYpGANAtwgzFjbsEfVCW4paSjA96MH9-PqNOc1QgR4K59Ux4QIAZLTk-r9rF5dzWeX76AZkx7y0g3B1Js4ZVd26_rax1TP403W5kdw1yFNuZ5hXm_1uIqFdjnkp9Vjr_vsnt2dZ9W3jx--zj83F18-Leazi8Yw2Y6NpUybjjFKQGIJ1grhHbfAXecBdwww9p0EijDymGgrWilZJ7xkHjuLBDmrFntdG_VabVPY6PRLRR3UbSCmpdJpDKZ3CgwAN4Z2UmvadZ3mWpbq3IDgxvK2aL3da22nbuOscUPpvz8QPXwZwkot47USiGNEeRF4dSeQ4s_J5VFtQjau7_XgyvgUMMwFJW27-_fLf9B1nNJQRlUoEJICFeQvtdSlgTD4WOqanaiacSYJbqWAQp3_hyrLuk0wxSA-lPhBwuuDhMKM7mZc6ilntbi6PGRhz5oUc07O388DI7XznNp7ThXPqVvPKVaSXjyc5H3KH5OR35jq0L0 |
CitedBy_id | crossref_primary_10_1128_aac_00054_24 crossref_primary_10_1038_s41592_023_01896_x crossref_primary_10_1016_j_virol_2024_109989 crossref_primary_10_3389_fmicb_2022_1101850 |
Cites_doi | 10.1038/s41374-020-0456-x 10.1097/INF.0000000000001242 10.1371/journal.ppat.1000082 10.1080/14760584.2018.1510326 10.1155/2020/9273241 10.1038/emi.2017.49 10.1186/1743-422X-10-250 10.1128/JVI.00902-12 10.1016/j.vaccine.2016.04.029 10.1128/JVI.02070-12 10.3389/fmicb.2020.00261 10.1016/j.antiviral.2014.02.015 10.1242/jcs.00075 10.1097/MD.0000000000011610 10.1016/S0962-8924(03)00005-9 10.1186/s12879-015-0965-1 10.1128/JVI.02358-10 10.1542/pir.19.6.183 10.1128/JVI.00692-14 10.1038/s41598-019-47455-3 10.1128/JVI.00020-12 10.1097/MD.0000000000018464 10.1128/JVI.06103-11 10.1002/path.4438 10.4049/jimmunol.1700352 10.4161/hv.27087 10.1111/nyas.13126 10.1093/hmg/ddg062 10.1073/pnas.1217563110 10.1038/srep34299 10.1016/j.coviro.2013.01.001 10.3389/fmicb.2020.00540 10.1371/journal.pone.0057591 10.1016/j.ajic.2015.04.202 10.3390/v7112916 10.1038/nm.1992 10.1016/j.vaccine.2019.07.046 10.1016/j.virol.2016.10.031 10.1186/s12929-020-0615-9 10.1016/j.virusres.2018.07.008 10.1038/srep31151 10.7883/yoken.JJID.2018.035 10.1097/INF.0000000000001093 10.1016/j.diagmicrobio.2013.02.011 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 3V. 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12985-021-01557-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Science ProQuest Central (Corporate) Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest - Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Virology and AIDS Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1743-422X |
EndPage | 84 |
ExternalDocumentID | oai_doaj_org_article_2c226cc4b9aa4bbba6a95ac6c286cd67 A659317982 10_1186_s12985_021_01557_5 33882964 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China United States--US |
GeographicLocations_xml | – name: China – name: United States--US |
GrantInformation_xml | – fundername: ; – fundername: ; grantid: 2018ZF006 – fundername: ; grantid: 2016-I2M-1-014 – fundername: ; grantid: 3332019004 – fundername: ; grantid: H-2017034 – fundername: ; grantid: 31700153 – fundername: ; grantid: 1540001 |
GroupedDBID | --- -A0 0R~ 123 29Q 2WC 3V. 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAHBH AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IFM IGS IHR INH INR ISR ITC KQ8 LGEZI LOTEE M1P M48 M~E NADUK NPM NXXTH O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX AFPKN CITATION AFGXO ABVAZ AFNRJ 7U9 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c597t-d45acb554329192dd88fe6d26ebf21b5211fb924010f13ad87995b8f95f1ed083 |
IEDL.DBID | RPM |
ISSN | 1743-422X |
IngestDate | Tue Oct 22 15:08:34 EDT 2024 Tue Sep 17 21:20:30 EDT 2024 Fri Oct 25 11:30:54 EDT 2024 Thu Oct 10 20:30:25 EDT 2024 Thu Feb 22 23:56:43 EST 2024 Tue Nov 12 23:14:38 EST 2024 Thu Aug 01 19:27:26 EDT 2024 Thu Sep 12 16:51:53 EDT 2024 Wed Oct 16 00:41:43 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Respiratory and neurological pathology Foot and mouth disease (HFMD) Coxsackievirus A16 (CA16) Human scavenger receptor class B Hand member 2 (hSCARB2) |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c597t-d45acb554329192dd88fe6d26ebf21b5211fb924010f13ad87995b8f95f1ed083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8335-5613 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061046/ |
PMID | 33882964 |
PQID | 2528942483 |
PQPubID | 55248 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2c226cc4b9aa4bbba6a95ac6c286cd67 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8061046 proquest_miscellaneous_2516843778 proquest_journals_2528942483 gale_infotracmisc_A659317982 gale_infotracacademiconefile_A659317982 gale_incontextgauss_ISR_A659317982 crossref_primary_10_1186_s12985_021_01557_5 pubmed_primary_33882964 |
PublicationCentury | 2000 |
PublicationDate | 2021-04-21 |
PublicationDateYYYYMMDD | 2021-04-21 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-21 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Virology journal |
PublicationTitleAlternate | Virol J |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | AT Liou (1557_CR31) 2016; 6 P Yao (1557_CR14) 2019; 37 N Ye (1557_CR40) 2015; 15 D Safronetz (1557_CR43) 2013; 3 J Wang (1557_CR19) 2017; 500 B-S Chen (1557_CR6) 2020; 11 A Majer (1557_CR7) 2020; 11 YT Hooi (1557_CR17) 2020; 100 1557_CR5 Y Sun (1557_CR16) 2016; 6 1557_CR1 CC Liao (1557_CR47) 2014; 88 Y-W Lin (1557_CR29) 2013; 8 K Kobayashi (1557_CR20) 2020; 27 S Yamayoshi (1557_CR22) 2009; 15 Q Zhu (1557_CR33) 2017; 198 EL Eskelinen (1557_CR27) 2003; 13 EA Caine (1557_CR13) 2015; 7 T Zaoutis (1557_CR11) 1998; 19 W Zhang (1557_CR38) 2020; 2020 X Li (1557_CR23) 2013; 10 K Fujii (1557_CR30) 2013; 110 DA Food (1557_CR41) 2002; 67 L Sun (1557_CR10) 2016; 44 C-Y Fang (1557_CR2) 2018; 17 C Li (1557_CR44) 2018; 255 D Zhu (1557_CR46) 2013; 76 A Muehlenbachs (1557_CR8) 2015; 235 S Yamayoshi (1557_CR24) 2013; 87 Q Liu (1557_CR12) 2014; 105 L Jian-Ping (1557_CR18) 2014; 35 WX Khong (1557_CR45) 2012; 86 SK Kuss (1557_CR48) 2008; 4 T Kuronita (1557_CR26) 2002; 115 S Zhou (1557_CR32) 2016; 34 H de Graaf (1557_CR3) 2016; 35 WK Phyu (1557_CR9) 2017; 6 Q Mao (1557_CR15) 2012; 86 S Yamayoshi (1557_CR21) 2012; 86 C Chang (1557_CR34) 2019; 9 S Yamayoshi (1557_CR25) 2011; 85 X Rao (1557_CR35) 2013; 3 D-q Yin (1557_CR37) 2018; 71 GD Park (1557_CR42) 2016; 1374 S Owatanapanich (1557_CR4) 2016; 99 AC Gamp (1557_CR28) 2003; 12 Q Mao (1557_CR36) 2014; 10 Y Xu (1557_CR39) 2019; 98 |
References_xml | – volume: 99 start-page: 322 year: 2016 ident: 1557_CR4 publication-title: J Med Assoc Thai contributor: fullname: S Owatanapanich – volume: 100 start-page: 1262 year: 2020 ident: 1557_CR17 publication-title: Lab Invest doi: 10.1038/s41374-020-0456-x contributor: fullname: YT Hooi – ident: 1557_CR1 doi: 10.1097/INF.0000000000001242 – volume: 4 start-page: e1000082 year: 2008 ident: 1557_CR48 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000082 contributor: fullname: SK Kuss – volume: 17 start-page: 819 year: 2018 ident: 1557_CR2 publication-title: Expert Rev Vaccines doi: 10.1080/14760584.2018.1510326 contributor: fullname: C-Y Fang – volume: 2020 start-page: 9273241 year: 2020 ident: 1557_CR38 publication-title: Mediators Inflamm doi: 10.1155/2020/9273241 contributor: fullname: W Zhang – volume: 6 start-page: 1 year: 2017 ident: 1557_CR9 publication-title: Emerg Microbes Infect doi: 10.1038/emi.2017.49 contributor: fullname: WK Phyu – volume: 10 start-page: 250 year: 2013 ident: 1557_CR23 publication-title: Virol J doi: 10.1186/1743-422X-10-250 contributor: fullname: X Li – volume: 86 start-page: 11967 year: 2012 ident: 1557_CR15 publication-title: J Virol doi: 10.1128/JVI.00902-12 contributor: fullname: Q Mao – volume: 34 start-page: 2729 year: 2016 ident: 1557_CR32 publication-title: Vaccine doi: 10.1016/j.vaccine.2016.04.029 contributor: fullname: S Zhou – volume: 87 start-page: 3335 year: 2013 ident: 1557_CR24 publication-title: J Virol doi: 10.1128/JVI.02070-12 contributor: fullname: S Yamayoshi – volume: 11 start-page: 261 year: 2020 ident: 1557_CR6 publication-title: Front Microbiol doi: 10.3389/fmicb.2020.00261 contributor: fullname: B-S Chen – volume: 105 start-page: 26 year: 2014 ident: 1557_CR12 publication-title: Antiviral Res doi: 10.1016/j.antiviral.2014.02.015 contributor: fullname: Q Liu – volume: 115 start-page: 4117 year: 2002 ident: 1557_CR26 publication-title: J Cell Sci doi: 10.1242/jcs.00075 contributor: fullname: T Kuronita – volume: 67 start-page: 37988 year: 2002 ident: 1557_CR41 publication-title: Fed Reg contributor: fullname: DA Food – ident: 1557_CR5 doi: 10.1097/MD.0000000000011610 – volume: 13 start-page: 137 year: 2003 ident: 1557_CR27 publication-title: Trends Cell Biol doi: 10.1016/S0962-8924(03)00005-9 contributor: fullname: EL Eskelinen – volume: 15 start-page: 225 year: 2015 ident: 1557_CR40 publication-title: BMC Infect Dis doi: 10.1186/s12879-015-0965-1 contributor: fullname: N Ye – volume: 85 start-page: 4937 year: 2011 ident: 1557_CR25 publication-title: J Virol doi: 10.1128/JVI.02358-10 contributor: fullname: S Yamayoshi – volume: 19 start-page: 183 year: 1998 ident: 1557_CR11 publication-title: Pediatrics Rev doi: 10.1542/pir.19.6.183 contributor: fullname: T Zaoutis – volume: 88 start-page: 12485 year: 2014 ident: 1557_CR47 publication-title: J Virol doi: 10.1128/JVI.00692-14 contributor: fullname: CC Liao – volume: 9 start-page: 11108 year: 2019 ident: 1557_CR34 publication-title: Sci Rep doi: 10.1038/s41598-019-47455-3 contributor: fullname: C Chang – volume: 86 start-page: 5686 year: 2012 ident: 1557_CR21 publication-title: J Virol doi: 10.1128/JVI.00020-12 contributor: fullname: S Yamayoshi – volume: 98 start-page: e18464 year: 2019 ident: 1557_CR39 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000018464 contributor: fullname: Y Xu – volume: 35 start-page: 485 year: 2014 ident: 1557_CR18 publication-title: Zool Res contributor: fullname: L Jian-Ping – volume: 86 start-page: 2121 year: 2012 ident: 1557_CR45 publication-title: J Virol doi: 10.1128/JVI.06103-11 contributor: fullname: WX Khong – volume: 235 start-page: 217 year: 2015 ident: 1557_CR8 publication-title: J Pathol doi: 10.1002/path.4438 contributor: fullname: A Muehlenbachs – volume: 198 start-page: 4210 year: 2017 ident: 1557_CR33 publication-title: J Immunol doi: 10.4049/jimmunol.1700352 contributor: fullname: Q Zhu – volume: 10 start-page: 360 year: 2014 ident: 1557_CR36 publication-title: Hum Vaccin Immunother doi: 10.4161/hv.27087 contributor: fullname: Q Mao – volume: 1374 start-page: 10 year: 2016 ident: 1557_CR42 publication-title: Ann N Y Acad Sci doi: 10.1111/nyas.13126 contributor: fullname: GD Park – volume: 12 start-page: 631 year: 2003 ident: 1557_CR28 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddg062 contributor: fullname: AC Gamp – volume: 110 start-page: 14753 year: 2013 ident: 1557_CR30 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1217563110 contributor: fullname: K Fujii – volume: 6 start-page: 34299 year: 2016 ident: 1557_CR16 publication-title: Sci Rep doi: 10.1038/srep34299 contributor: fullname: Y Sun – volume: 3 start-page: 205 year: 2013 ident: 1557_CR43 publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2013.01.001 contributor: fullname: D Safronetz – volume: 11 start-page: 540 year: 2020 ident: 1557_CR7 publication-title: Front Microbiol doi: 10.3389/fmicb.2020.00540 contributor: fullname: A Majer – volume: 8 start-page: e57591 year: 2013 ident: 1557_CR29 publication-title: PLoS ONE doi: 10.1371/journal.pone.0057591 contributor: fullname: Y-W Lin – volume: 44 start-page: e13 year: 2016 ident: 1557_CR10 publication-title: Am J Infect Control doi: 10.1016/j.ajic.2015.04.202 contributor: fullname: L Sun – volume: 7 start-page: 5919 year: 2015 ident: 1557_CR13 publication-title: Viruses doi: 10.3390/v7112916 contributor: fullname: EA Caine – volume: 3 start-page: 71 year: 2013 ident: 1557_CR35 publication-title: Biostat Bioinforma Biomath contributor: fullname: X Rao – volume: 15 start-page: 798 year: 2009 ident: 1557_CR22 publication-title: Nat Med doi: 10.1038/nm.1992 contributor: fullname: S Yamayoshi – volume: 37 start-page: 5341 year: 2019 ident: 1557_CR14 publication-title: Vaccine doi: 10.1016/j.vaccine.2019.07.046 contributor: fullname: P Yao – volume: 500 start-page: 198 year: 2017 ident: 1557_CR19 publication-title: Virology doi: 10.1016/j.virol.2016.10.031 contributor: fullname: J Wang – volume: 27 start-page: 23 year: 2020 ident: 1557_CR20 publication-title: J Biomed Sci doi: 10.1186/s12929-020-0615-9 contributor: fullname: K Kobayashi – volume: 255 start-page: 117 year: 2018 ident: 1557_CR44 publication-title: Virus Res doi: 10.1016/j.virusres.2018.07.008 contributor: fullname: C Li – volume: 6 start-page: 31151 year: 2016 ident: 1557_CR31 publication-title: Sci Rep doi: 10.1038/srep31151 contributor: fullname: AT Liou – volume: 71 start-page: 470 year: 2018 ident: 1557_CR37 publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2018.035 contributor: fullname: D-q Yin – volume: 35 start-page: 723 year: 2016 ident: 1557_CR3 publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000001093 contributor: fullname: H de Graaf – volume: 76 start-page: 162 year: 2013 ident: 1557_CR46 publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2013.02.011 contributor: fullname: D Zhu |
SSID | ssj0032679 |
Score | 2.3575485 |
Snippet | Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease (HFMD),... Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and... Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth... BACKGROUNDCoxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and mouth disease... Abstract Background Coxsackievirus A16 (CA16) is one of the neurotropic pathogen that has been associated with severe neurological forms of hand, foot, and... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 84 |
SubjectTerms | Alveoli Analysis Animal models Animals Antigens Antigens, Viral Brain stem Capillaries Coxsackievirus Coxsackievirus A16 (CA16) Coxsackievirus Infections Coxsackieviruses Disease Models, Animal Enterovirus Foot and mouth disease (HFMD) Hand Hand-foot-and-mouth disease Health aspects Host range Host-virus relationships Human scavenger receptor class B IL-1β Immune response Infections Inflammation Interleukin 18 Interleukin 6 Laboratory animals Lymphocytes Medical research member 2 (hSCARB2) Mice Mice, Transgenic Mucosa Neurological diseases Pathogenesis Pathogenicity Pathology Respiratory and neurological pathology Rodents Scavenger receptors Transgenic animals Transgenic mice Tropism Virulence (Microbiology) Virus Replication Virus research Viruses γ-Interferon |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RAFB-koHgRW79Sq0QRPMjQzXxlckxXSxXqobXQ2zAfmXYRstLsgv73fW8mu2zw4MXbknkJm997M-_9yPsg5AOLGs79IKiDaJ4iQ6DAVRS1-JMrHmKqrTr_rs6uxLdreb0z6gtzwnJ74AzcMfMQIHgvXGOtcM5ZZRtpvfJMKx9UriOfNRsylc9giEnqZlMio9XxAF5NYyUyUmcpayonbih16__7TN5xStOEyR0PdPqUPBlDx7LNf3mfPOj6A_IwD5P8c0AenY-fyZ-Rz215ezlvL04YXaEvAiNZ-BJJflem0TclhKrlfPl7sP7nAvN810PZVqrE-cTLGzz-FsNzcnX65cf8jI7jEqgHVrCiQQAuDsIDzhqI20LQOnYqMNW5yCoHfrqKDugWMLBYcRs09oJzOjYyVl2AUOwF2euXffeKlAAsgAzcDx4ivJZ6hsOFoorwOOe5LsinDXrmV-6KYRKb0MpkrA1gbRLWRhbkBAHeSmJH63QB9GxGPZt_6bkg71E9BntW9JgUc2PXw2C-Xl6YVsmGY-M1VpCPo1BcAr7ejjUG8FbY5moieTSRhE3lp8sbKzDjph4Mk2DPggnNC_Juu4x3YqJa34EWQaZSWvC6BoxeZqPZvjfnQGcaJQpST8xpAsx0pV_cppbfGsKumVCH_wPJ1-QxSztBUFYdkb3V3bp7A5HVyr1Nm-geDzEeIg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96ovgien5VT6ki-CDhtvlq-iS91eMUzoc7D_YtJGmztwjted0F_e-dSbPrFcG30kxDOplkfr92MkPIOxY07PuNoA7QPEWGQIGrKGrxkivehHi26vSbOrkQXxdykT64DSmscrsnxo266T1-Iz9kEjoTTGj-8eonxapR-Hc1ldC4Te4UbKYwpKtc7AgXIJOYaw9BNxWMLbaHZrQ6HMDPaTybjGRaypLKiWOK-fv_3aVvuKlpCOUNn3T8kDxIYDKvx9l_RG613T65O5aX_L1P7p2mH-ePyac6vzyf12dHjK7RO4HZrHyOtL_NYzGcHMBrPu9_Ddb_WGHk72bI60LlWLG4X-KGuBqekIvjz9_nJzQVUKAeeMKaNkJa7wAwcFYBkmsarUOrGqZaF1jhwHMXwQEBA04WCm4bjdnhnA6VDEXbADh7Sva6vmufk9w3qpIW2CB0IryWeoblhoIK0J3zXGfkw1Z75mrMk2Eiv9DKjLo2oGsTdW1kRo5QwTtJzHEdb_TXS5OWjGEeoKH3wlXWCuecVRaG4JVnWsFwyoy8xekxmMWiwzCZpd0Mg_lyfmZqJSuOqdhYRt4nodCDfr1Npw7grTDx1UTyYCIJy8xPm7dWYNIyH8xfo8zIm10zPomha10LswgyhdKClyXo6NloNLv35hwITqVERsqJOU0UM23pVpcxCbgGIDYT6sX_h_WS3GfRxgVlxQHZW19v2leAotbudVwqfwCAzRYh priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGEIgXBOMrMFBASDwgs8VfcR4QygrTQBoPG5X6ZtlO3FWgBJpW2v577tykWsTEW1VfLOdy5_v9kvMdIW9Z0LDvV4I6QPMUGQIFrqKoxZ9c8SrEs1Wn39XJVHybydkOGdod9QrsbqR22E9quvz14fLP1Sdw-I_R4bU66CBmaTxnjMRYypzKW-Q2E8DUMZVPbL8qAFKJtfcQhFPB2Gw4RHPjHKNAFev5_7trXwtb45TKazHq-AG534PLtNxYw0OyUzd75M6m3eTVHrl72n9If0Q-l-nF-aQ8O2J0hdEKzGjhU3wNUKexOU4KYDadtJed9T8XmAm87tIyUyl2MG7nuEEuusdkevzlx-SE9g0VqAfesKKVkNY7ABCcFYDsqkrrUKuKqdoFljmI5FlwQMiAo4WM20pjtTinQyFDVlcA1p6Q3aZt6mck9ZUqpAV2CJMIr6U-xPZDQQWYznmuE_J-0J75vambYSLf0MpsdG1A1ybq2siEHKGCt5JY8zr-0S7npnchwzxARe-FK6wVzjmrLCzBK8-0guXkCXmDj8dgVYsG02bmdt115uv5mSmVLDiWZmMJedcLhRb0621_CgHuCgthjST3R5Lgdn48PFiBGazWMAkWL5jQPCGvt8N4JaayNTU8RZDJlBY8z0FHTzdGs71vzoHwFEokJB-Z00gx45FmcRGLgmsAZodCPf__sl6QeyzauKAs2ye7q-W6fgmoauVeRVf5C05bGU0 priority: 102 providerName: Scholars Portal |
Title | A hSCARB2-transgenic mouse model for Coxsackievirus A16 pathogenesis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33882964 https://www.proquest.com/docview/2528942483 https://search.proquest.com/docview/2516843778 https://pubmed.ncbi.nlm.nih.gov/PMC8061046 https://doaj.org/article/2c226cc4b9aa4bbba6a95ac6c286cd67 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2IRAvCMZXYFQBIfGAshLHdpzHtGwaSJ2mjkl9s2wn7iJYMi2tBP89d05SLeKNl6iKL5FzvvPdr74PQj5SJ2HfL1hkwJuPECFEgFVEpPFnIpLC-dyqxbk4u2LfV3y1R_iQC-OD9q2pjutfN8d1de1jK29v7HSIE5teLOYSjBAeTe6TfRDQAaJ32y-4I2k2ZMdIMW3BoElMQkbUzHkaYa8awGUSzxtHxsjX7P93Z75nmsZhk_fs0OlT8qR3IMO8m-gzslfWh-Rh11LyzyF5tOgPy5-Tr3l4fTnPlzMabdAigahUNkSoX4a-AU4IDms4b3632v6sMNp324Z5LELsUtyscROs2hfk6vTkx_ws6psmRBawwSYqGNfWgJOQ0Ay8t6KQ0pWioKI0jsYGrHXsDIAuwGEuTnQhsSKckS7jLi4LcMhekoO6qcvXJLSFyLgGBAgvYVZy-QVbDDnh4HXGJjIgnwfuqduuNobymEIK1bFdAduVZ7viAZkhg3eUWNfa32ju1qpfXUUtuIPWMpNpzYwxWmiYghWWSgHTSQPyAZdHYeWKGkNj1nrbturb5VLlgmcJll-jAfnUE7kG-Gt1n2kAX4XFrkaURyNKUC07Hh6kQPWq3SrKQaoZZTIJyPvdMD6J4Wp1CasINLGQLElT4NGrTmh23z3IXkDSkTiNGDMeAT3whb97uX_z30--JY-p1wQW0fiIHGzutuU7cKo2ZgKqtEon5MHs5PxiOfF_TcB1weTEq9dfKPghXg |
link.rule.ids | 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagiMcFQXk0UCAgJA7IauPYjnNC24VqC90e-pD2ZtlOvF0hJW2zK8G_Z8bxLo2QuEXxxHLG45nvS-wZQj4yr8DvV5xaQPMUGQIFriKpwctc5pUPZ6umJ3Jywb_PxCx-cOvitsq1TwyOumodfiPfYwI644yr_MvVNcWqUfh3NZbQuEvuYR4urGBQzDaEC5BJyLWHoJtyxmbrQzNK7nUQ5xSeTUYyLURBxSAwhfz9_3rpW2FquIXyVkw6fEIeRzCZjvrZf0ru1M02ud-Xl_y9TR5M44_zZ-TrKL08G49ODxhdYnQCs1m4FGl_nYZiOCmA13Tc_uqM-7nAnb-rLh1lMsWKxe0cHeKie04uDr-djyc0FlCgDnjCklZcGGcBMOSsBCRXVUr5WlZM1tazzELkzrwFAgaczGe5qRRmh7PKl8JndQXg7AXZatqm3iGpq2QpDLBB6IQ7JdQ-lhvy0kN31uUqIZ_X2tNXfZ4MHfiFkrrXtQZd66BrLRJygAreSGKO63CjvZnruGQ0cwANneO2NIZba400MAQnHVMShlMk5ANOj8YsFg1uk5mbVdfpo7NTPZKizDEVG0vIpyjkW9CvM_HUAbwVJr4aSO4OJGGZuWHz2gp0XOad_muUCXm_acYncetaU8MsgkwmFc-LAnT0sjeazXvnORCcUvKEFANzGihm2NIsLkMScAVAbJ_LV_8f1jvycHI-PdbHRyc_XpNHLNg7pyzbJVvLm1X9BhDV0r4Ny-YPoskZCA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwELZgiIkXBANGYEBASDwgr4vjOM5j11FtQKdpY9LeLNuJu2hbUi2tBP-eOyepGvHGW1VfIud85_s--XxHyGfmJOz7OacG0DxFhkCBqwiq8Wcs4tz5u1WzU3F8yb9fJVcbrb580r415X51e7dfldc-t3JxZ0d9ntjobDaREITwaHKRu9FD8gh89kD0RL3dhAGUpFl_R0aKUQNhTeJVZOTOSZJS7FgD7EziqeMgJPnK_f_uzxsBapg8uRGNps_I0w5GhuN2us_Jg6LaIY_bxpJ_dsj2rDsyf0GOxuH1xWR8fsjoEuMSGExpQyT8Rejb4IQAW8NJ_bvR9qbEnN9VE44jEWKv4nqOW2HZvCSX02-_Jse0a51ALTCEJc15oq0BqBCzDDBcnkvpCpEzURjHIgMxO3IGqBewMRfFOpdYF85IlyUuKnKAZa_IVlVXxWsS2lxkiQYeCC_hVibyABsNOeHgdcbGMiBfe-2pRVshQ3lmIYVq1a5A7cqrXSUBOUQFryWxurX_o76fq26NFbMACq3lJtOaG2O00DAFKyyTAqaTBuQTLo_C-hUVJsjM9app1MnFuRqLJIuxCBsLyJdOyNWgX6u7-wbwVVjyaiC5N5AEB7PD4d4KVOfgjWIJ2DZnXMYB-bgexicxaa0qYBVBJhKSx2kKOtptjWb93b3tBSQdmNNAMcMR8AZf_ruz_jf__eQHsn12NFU_T05_vCVPmHcKTlm0R7aW96viHaCspXnv_ekvS-Ihdw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+hSCARB2-transgenic+mouse+model+for+Coxsackievirus+A16+pathogenesis&rft.jtitle=Virology+journal&rft.au=Chen%2C+Yanli&rft.au=Li%2C+Heng&rft.au=Yang%2C+Jinxi&rft.au=Zheng%2C+Huiwen&rft.date=2021-04-21&rft.pub=BioMed+Central&rft.issn=1743-422X&rft.eissn=1743-422X&rft.volume=18&rft.spage=1&rft_id=info:doi/10.1186%2Fs12985-021-01557-5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon |